Dr. Justin M. Watts, MD

Dr. Watts practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Watts' NPI, 1750517959, was assigned on June 3, 2009. Dr. Watts graduated from Emory School of Medicine in 2007. Dr. Watts holds Florida license ME120302.

Dr. Watts' primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Watts' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Watts is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Watts practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Watts' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Watts' licenses on file in 3 states: Florida, California and New York.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT) and purpura and thrombocytopenia among the conditions Dr. Watts treats.

CMS data shows 163 Medicare services from Dr. Watts across 3 procedure codes in 2024, for 44 Medicare patients. Medicare paid $17,645 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 44 Medicare patients who saw Dr. Watts in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 3.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Watts' median patient age at 72, with 42% women.

In 2024, Dr. Watts wrote 611 Medicare Part D claims for 91 patients. 44% of them were for generic drugs. CMS names the drug for 506 of them, across 20 drugs with 11 or more claims each, at $5,144,141 in total drug cost. In 2023, CMS named 324 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Watts for performance year 2024, reported as part of a group. Dr. Watts accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Watts as offering telehealth.

Dmand AI links 59 papers to Dr. Watts, published from 2014 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Leukemia, Myeloid, Acute, Isocitrate Dehydrogenase and Pyridines. Dr. Watts has published most often in Leukemia. Dr. Watts' most frequent co-authors are Terrence J. Bradley, MD, Ronan Thomas Swords, MD and Justin W. Taylor, MD.

Dmand AI links Dr. Watts to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 319 general payments to Dr. Watts from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. Rigel Pharmaceuticals, Inc. paid the most, $34,710. It also lists 16 research payments totaling $70,531 from 2019 to 2023.

Dr. Watts graduated from Emory School of Medicine in 2007.

Dr. Watts is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.